Diseases, Conditions, Syndromes

Ending tuberculosis is a race against time and drug resistance

The tuberculosis (TB) burden in the WHO European Region as a whole is decreasing, and is down 19% overall for 2015-2019, according to the latest WHO/European Center for Disease Prevention and Control (ECDC) report Tuberculosis ...

Diseases, Conditions, Syndromes

S.Africa trial shows promise for drug-resistant TB regimen

Almost all patients who received a new treatment for highly drug-resistant tuberculosis are still clear of the disease two years after a medical trial in South Africa, findings from a long-term study showed Thursday.

Medications

New tuberculosis drug regimen slashes treatment time

Tuberculosis is an age-old respiratory scourge, with a new twist: growing resistance to multiple first- and second-line drugs. UF researchers and physicians report on using a novel treatment to slash treatment time—and ...

Medical research

Fighting the good fight against bacteria

Drug-resistant bacteria could lead to more deaths than cancer by 2050, according to a report commissioned by the United Kingdom in 2014 and jointly supported by the U.K. government and the Wellcome Trust. In an effort to ...

Diseases, Conditions, Syndromes

Drug-resistant tuberculosis reversed in lab

About 1.5 million people died of tuberculosis (TB) in 2017, making it the most lethal infectious disease worldwide. A growing rise in drug-resistant TB is a major obstacle to successfully treating the illness.

Diseases, Conditions, Syndromes

Drug-resistant tuberculosis: A new study offers new hope

Tuberculosis (TB) is the leading cause of death in the world from a single infectious disease, causing more deaths than HIV/AIDS. In 2017, 10 million people developed TB disease globally and an estimated 1.6 million died.

page 3 from 13